Analyst Update: Match Group Inc, Teva Pharmaceutical Industries Ltd, and Michael Kors Holdings Ltd

Analysts adjusted their ratings on Match Group Inc (NASDAQ:MTCH), Teva Pharmaceutical Industries Ltd (ADR) (TEVA), and Michael Kors Holdings Ltd (KORS)

by Kirra Fedyszyn

Published on Nov 23, 2015 at 12:16 PM

Analysts are weighing in today on Internet dating concern Match Group Inc (NASDAQ:MTCH), drug company Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), and luxury retailer Michael Kors Holdings Ltd (NYSE:KORS). Here's a quick roundup of today's brokerage notes on MTCH, TEVA, and KORS.

  • MTCH was last seen trading at $14.87, a loss of 2.2%, after finishing Friday at a 27% premium to its $12.00 initial public offering (IPO) price on Thursday. Two brokerage firms initiated coverage on the shiny new stock today, with BTIG doling out a bearish "sell" rating and $11 price target, while Axiom gave Match Group Inc a bullish nod, with a "buy" rating and $18 price target. However, eager speculators will have to keep waiting before options can be traded on Match Group Inc.

  • TEVA received a rating boost to "buy" from "neutral" at Goldman Sachs, helping the shares climb 1.2% to $62.41 so far today. Teva Pharmaceutical Industries Ltd may be enjoying some extra attention thanks to major M&A news from sector peer Pfizer Inc. (NYSE: PFE). TEVA reported quarterly earnings above estimates last month, and has gained favor with analysts and options traders alike. Of the 17 firms following TEVA, 12 give it a "buy" rating or better. Even more impressive, the stock's 50-day call/put volume ratio on the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) of 6.91 is higher than 93% of readings from the last 52 weeks -- meaning options buyers have rarely purchased calls over puts at a faster clip.

  • It's a good day on the charts so far for KORS, last seen up 1.7% to trade at $41.82, despite a price-target cut to $45 from $46 at Goldman Sachs. Michael Kors Holdings Ltd has been trending mostly sideways for months, ever since staging a late-May bear gap after earnings. The luxury brand beat quarterly earnings expectations earlier this month, but has yet to stage a convincing breakout above resistance at its 20-week moving average. As it stands, analysts are rather uncertain concerning the future of this stock, with 15 of the 19 brokerages following KORS maintaining a tepid "hold" rating, and just a few outliers on either side of the fence.
For other stocks in analysts' crosshairs, read Analyst Upgrades: Horizon Pharma PLC, Panera Bread Co, and Microsoft Corporation, and Analyst Downgrades: Ambarella Inc, QUALCOMM, Inc., and Sunedison Inc.

A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earning announcements before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


With This Lithium Stock, It Will Be Better to Be Too Early Than Too Late
Click to continue to advertiser's site.
American Airlines Drops on Jobs Update
American Airlines said it will reduce management and support staff by 30%
June Kicks Off With Slew of Economic Data
June begins with another round of retail earnings
With This Lithium Stock, It Will Be Better to Be Too Early Than Too Late
Click to continue to advertiser's site.